Yili Chen resumes & CV records
Resumes
Yili Chen
Yili U Chen, 4939 Magnolia Way, Chadds Ford, PA 19317
Yili Chen Phones & Addresses
Chadds Ford, PA
1349 Wooded Knls, West Chester, PA 19382 610-7931989
O Fallon, MO
Newark, DE
Houston, TX
Chesterfield, MO
Ann Arbor, MI
Dublin, OH
Mentions for Yili U Chen
Publications & IP owners
Us Patents
Bicyclic Heterocyclic Compounds As Pde2 Inhibitors
US Patent:
2018014, May 24, 2018
Filed:
Jun 27, 2016
Appl. No.:
15/736202
Inventors:
Shawn J. STACHEL - West Point PA, US
Christopher J. SINZ - Rahway NJ, US
Yili CHEN - Rahway NJ, US
Jonathan E. WILSON - Rahway NJ, US
Michael P. DWYER - Rahway NJ, US
Daniel V. PAONE - Lansdale PA, US
Shimin XU - Beijing, CN
- Rahway NJ, US
Christopher J. SINZ - Rahway NJ, US
Yili CHEN - Rahway NJ, US
Jonathan E. WILSON - Rahway NJ, US
Michael P. DWYER - Rahway NJ, US
Daniel V. PAONE - Lansdale PA, US
Shimin XU - Beijing, CN
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 487/04
A61P 25/18
A61P 25/22
A61P 25/28
A61P 25/06
A61P 25/16
A61P 25/18
A61P 25/22
A61P 25/28
A61P 25/06
A61P 25/16
Abstract:
The present invention is directed to dihydropyrazolopyrimidinone compounds of formulas (I) and (II) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis, Parkinson's disease, Parkinson's disease dementia (PDD), or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.